six-week-old male balb/c nu/nuspecific and opportunistic pathogen-tree (sopf) mice (Janvier Labs)
90
Structured Review
Janvier Labs
six-week-old male balb/c nu/nuspecific and opportunistic pathogen-tree (sopf) mice
Six Week Old Male Balb/C Nu/Nuspecific And Opportunistic Pathogen Tree (Sopf) Mice, supplied by Janvier Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tree+pathogens/six+week+old+male+balb+c+nu+nuspecific+and+opportunistic+pathogen+tree++sopf++mice/pm39395152-296-5-9
Average 90 stars, based on 1 article reviews
Six Week Old Male Balb/C Nu/Nuspecific And Opportunistic Pathogen Tree (Sopf) Mice, supplied by Janvier Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tree+pathogens/six+week+old+male+balb+c+nu+nuspecific+and+opportunistic+pathogen+tree++sopf++mice/pm39395152-296-5-9
Average 90 stars, based on 1 article reviews
six-week-old male balb/c nu/nuspecific and opportunistic pathogen-tree (sopf) mice - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: [ 212 Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors. Article Snippet: Six-week-old male Balb/c nu/nu-specific and Article Title: eSOMA-DM1, a Maytansinoid-Based Theranostic Small-Molecule Drug Conjugate for Neuroendocrine Tumors. Article Snippet: Background: The main challenges of conventional chemotherapy lie in its lack of selectivity and specificity, leading to significant side effects.. Using a small-molecule drug conjugate (SMDC) ensures specific delivery of a cytotoxic drug to the tumor site by coupling it to a targeting vector.. This promising strategy can be applied to neuroendocrine tumors (NETs) by choosing a targeting vector that binds specifically to somatostatin receptor subtype 2 (SSTR2). |